ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Life Science Alliance · 2023-09 · 6 (9) · e202201880
DOI: 10.26508/lsa.202201880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 04.07.2023. Verfasst von Melanie Engler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg.
Abstract (Originalsprache)
SARS-CoV-2 triggered the most severe pandemic of recent times. To enter into a host cell, SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2). However, subsequent studies indicated that other cell membrane receptors may act as virus-binding partners. Among these receptors, the epidermal growth factor receptor (EGFR) was hypothesized not only as a spike protein binder, but also to be activated in response to SARS-CoV-2. In our study, we aim at dissecting EGFR activation and its major downstream signaling pathway, the mitogen-activated signaling pathway (MAPK), in SARS-CoV-2 infection. Here, we demonstrate the activation of EGFR–MAPK signaling axis by the SARS-CoV-2 spike protein and we identify a yet unknown cross talk between ACE2 and EGFR that regulated ACE2 abundance and EGFR activation and subcellular localization, respectively. By inhibiting the EGFR-MAPK activation, we observe a reduced infection with either spike-pseudotyped particles or authentic SARS-CoV-2, thus indicating that EGFR serves as a cofactor and the activation of EGFR-MAPK contributes to SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
- Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
- Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany ion.cirstea@uni-ulm.de.
ORCID-Profile: Melanie Engler, Dan Albers, Jan Münch, Ion Cristian Cirstea
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
Zitieren
APA
Engler, M., Albers, D., Von Maltitz, P., Groß, R., Münch, J., & Cirstea, I. C. (2023). ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection. Life Science Alliance, 6(9), e202201880. https://doi.org/10.26508/lsa.202201880
Vancouver
Engler M, Albers D, Von Maltitz P, Groß R, Münch J, Cirstea IC. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection. Life Science Alliance. 2023;6(9):e202201880. doi:10.26508/lsa.202201880
BibTeX
@article{Engler2023,
author = {Engler, Melanie and Albers, Dan and Von Maltitz, Pascal and Groß, Rüdiger and Münch, Jan and Cirstea, Ion Cristian},
title = {ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection},
journal = {Life Science Alliance},
year = {2023},
volume = {6},
number = {9},
pages = {e202201880},
doi = {10.26508/lsa.202201880}
}
EUVIMED